Atrium Therapeutics Revenue

In the year 2025, Atrium Therapeutics had annual revenue of $18.62M with 70.85% growth. Atrium Therapeutics had revenue of $859.00K in the quarter ending December 31, 2025.

Revenue (ttm)

$18.62M

Revenue Growth

+70.85%

P/S Ratio

10.77

Revenue / Employee

n/a

Employees

n/a

Market Cap

200.61M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	18.62M	7.72M	70.85%
Dec 31, 2024	10.90M	1.13M	11.60%
Dec 31, 2023	9.76M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

RNA News

12 days ago - Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration - PRNewsWire
14 days ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Month - Benzinga
14 days ago - Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
2 months ago - Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies - PRNewsWire
2 months ago - Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - PRNewsWire
2 months ago - Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders - PRNewsWire
2 months ago - The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1 - PRNewsWire
3 months ago - Avidity Biosciences Announces Expected Record Date for Spin-Off - PRNewsWire

More News